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Mast cellRecent pharmacological and molecular genetic approaches have revealed the existence of functional L-type
Ca2+ channels (LTCCs) in a variety of hematopoietic cells. We previously reported that Cav1.2 LTCCs are
expressed on mast cell surfaces, activated by the high-afﬁnity IgE receptor (FcɛRI) engagement and protect
mast cells against activation-induced cell death (AICD). We also demonstrated that FcɛRI engagement evokes
nitric oxide (NO) generation in a phosphatidylinositol-3-kinase- and NO synthase (NOS)-dependent manner,
which is also required for mast cell survival. Here we demonstrate that this endogenous NO mediates Cav1.2
LTCC activation. FcɛRI engagement but not thapsigargin, a potent Ca2+ release-activated Ca2+ (CRAC)
channel agonist, induced Ca2+ inﬂux via NOS-dependent NO generation. RT-PCR analyses revealed
predominant expression of eNOS in mast cells. Subsequent experiments involving siRNA-mediated gene
silencing of eNOS or Cav1.2 LTCC revealed that eNOS was essential for NOS-dependent NO generation and
Cav1.2 LTCC activation but not CRAC channel activation. Similar to Cav1.2 LTCCs, eNOS prevented the
dissipation of the mitochondrial membrane potential and mitochondrial integrity collapse, thereby
protecting mast cells against AICD. Taken together, the present ﬁndings demonstrate the key roles of the
eNOS-NO-LTCC axis in mast cell survival after FcɛRI engagement.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
Ca2+ is a highly versatile intracellular second messenger in many
cell types and regulates many complicated cellular processes,
including cell activation, proliferation and apoptosis. In resting cells,
cytosolic free Ca2+ concentration ([Ca2+]c) is maintained a low level
(50–150 nM). However, agonists including hormones, growth factors
and antigens (Ags) induce changes in the intracellular Ca2+ dynamics,
including elevation of [Ca2+]c, via mobilization of Ca2+ from
intracellular stores such as the endoplasmic reticulum (ER) and
mitochondria and the extracellular ﬂuid. Inﬂux of Ca2 from the
extracellular ﬂuid is required for sustained [Ca2+]c elevation and full
activation of Ca2+-dependent processes. It is widely accepted that
store-operated Ca2 entry (SOCE) is the main mode of Ca2+ inﬂux in
electrically non-excitable cells including mast cells [1,2]. SOCE is
mediated by store-operated Ca2+ (SOC) channels, which are activated
by depletion of the Ca2+ stores in the ER. Activation of cells by
agonists, such as receptor engagement by multivalent Ags, induces
the activation of phosphoinositide-speciﬁc phospholipase C (PLC).
PLC breakdowns phosphatidylinositol-4,5-bisphosphate to generate
two second messengers, inositol-1,4,5-triphosphate (IP3) and diacyl-
glycerol. IP3 binds to IP3 receptors located on the surface of the ER and
activates the release of Ca2+. The resulting store depletion activates+81 3 3972 8227.
ki).
ll rights reserved.SOCs in the plasma membrane to allow Ca2+ entry by mechanisms
that remain to be elucidated [3–5]. SOCs are also activated by
pharmacological emptying of intracellular stores via the actions of
pharmacological agents, such as thapsigargin (Tg) [6-8]. The best
characterized SOC current in immune cells is the current passing
through Ca2+ release-activated Ca2+ (CRAC) channels, ICRAC, which
was originally identiﬁed in rat basophilic leukemia (RBL) mast cells
[9] and Jurkat T cells [10]. Recent evidence suggests that the
mammalian proteins stromal interaction molecule 1 (STIM1) func-
tions as a sensor of store depletion, while several proteins, including
Orai1/Ca2+ release-activated Ca2+ modulator 1 and transient
receptor potential canonical proteins may act as channel-forming
molecules in CRAC channels in a variety of mammalian cells [11,12].
However, themolecular entities of the CRAC channels remain amatter
of debate, probably because they have multimeric structures.
Mast cells play critical roles in allergic and inﬂammatory reactions
as well as in innate and acquired immunity [13]. Upon Ag stimulation
of the high-afﬁnity IgE receptor (FcɛRI), mast cells release preformed
mediators such as histamine and serotonin and initiate new synthesis
and secretion of arachidonic acid metabolites such as leukotrienes
(LTs), cytokines and chemokines, which participate in the regulation
of other inﬂammatory cells [13]. Ca2+ inﬂux is required for the signal
transduction pathways that lead to degranulation, LT, and cytokine,
and chemokine production. Speciﬁc roles for CRAC channel-mediated
Ca2+ inﬂux have recently been demonstrated in mast cells derived
from Orai1- and STIM1-knockout mice. Mast cells lacking either
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FcɛRI-mediated in vivo anaphylaxis is strongly inhibited in Orai1-
knockoutmice and to a lesser extent in STIM1-knockoutmice [14–16].
The release of Ca2+ from the ER stores is similar between wild-type
and Orai1-knockout mice, thereby indicating that CRAC channel-
mediated Ca2+ inﬂux is crucial for degranulation. It was also revealed
that LT secretion is strongly inhibited in Orai1-knockout mice [15].
Taken together, CRAC channel-mediated Ca2+ inﬂux is involved in the
release of proinﬂammatory lipid mediators. Increased [Ca2+]c acti-
vates NFAT and NF-κB, which regulate the transcription of genes
encoding cytokines. Therefore, the overall cytokine production was
also expected to be affected in Orai1- or STIM1-knockout mice.
However, the results revealed that individual cytokine is affected
differently. For example, the secretion of tumor necrosis factor (TNF)-
α is much lower in Orai1- or STIM1-knockout mice, whereas the
secretion of interleukin (IL)-6 is minimally affected [14,15]. Therefore,
the Ca2 inﬂux pathways involved in the regulation of cytokine gene
expression may be more complicated than previously thought. Upon
mast cell activation, both SOCs and receptor-operated Ca2 channels
(ROCs) are activated to allow Ca2+ entry into the cell [17–19].
Speciﬁcally, a SOC-independent phosphatidylinositol-3,4,5-trispho-
sphate (PIP3)-sensitive Ca2 inﬂux mechanism has been demonstrated
in RBL-2H3 cells [17], although the molecular entities of the channels
responsible for this Ca2 inﬂux remain unclear.
L-type Ca2+ channels (LTCCs) are activated by membrane
depolarization and serve as the principal routes of Ca2+ entry into
electrically excitable cells such as neurons and myocytes. However,
recent pharmacological and molecular genetic approaches have
revealed the existence of functional LTCCs and/or LTCC-like channels
in a variety of hematopoietic cells such as B cells [20,21], dendritic
cells [22,23], NK cells [24], neutrophils [25] and T cells [26–29]. We
previously reported that mouse bone marrow-derived mast cells
(BMMCs) and RBL-2H3 cells express substantial amounts of Cav1.2
LTCCα1C subunit transcripts and proteins, which possess dihydropyr-
idine (DHP)-binding activity on their cell surface [30]. We also
demonstrated that Cav1.2 LTCCs are activated by Ag stimulation to
regulate mediator release in a distinct manner from SOCs [30]. These
ﬁndings suggest that mast cells express functional LTCCs that are
involved in cell activation. More recently, we demonstrated that
Cav1.2 LTCCs exhibit a pro-apoptotic function. Ag stimulation has a
minimal effect on mast cell survival in normal cells but induces
considerable apoptosis in α1C-knocked down cells. Subsequent
experiments suggested that Cav1.2 LTCCs are essential for the
maintenance of mitochondrial integrity [31]. In another line of
study, we demonstrated that mast cells generate nitric oxide (NO)
by a phosphatidylinositol-3-kinase (PI3K)-Akt-NO synthase (NOS)
pathway and that this NO generation preventsmitochondrial integrity
collapse, thereby protecting mast cells against Ag-induced apoptosis
[32]. These similarities in functions led us to examine the possible
relationship between NO and activation of Cav1.2 LTCCs. Our data
demonstrate that endothelial NOS (eNOS) is essential for NO
generation, Cav1.2 LTCC activation and survival in Ag-stimulated cells.
2. Materials and methods
2.1. Materials
Thapsigagin (Tg), Nω-nitro-L-arginine methyl ester (L-NAME) and
Nω-monometyl-L-arginine (L-NMMA) were obtained from Sigma-
Aldrich (St. Louis, MO). 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimi-
dazoline-1-oxyl-3-oxide (carboxy-PTIO) was obtained from Dojindo
Laboratories (Kumamoto, Japan). Benzyloxycarbonyl-Asp-Glu-Val-
Asp-ﬂuoromethylketone (z-DEVD-fmk) and nifedipine were obtained
from Calbiochem (San Diego, CA). DAF-FM-DA was obtained from
Sekisui Medical Co. (Tokyo, Japan). Wortmannin (WT), 2,4-diamino-6
(R,S)-6-(L-erythro-1′,2′-dihydroxypropyl)-5,6,7,8-tetrahydropteri-dine (amino-BH4), 2-aminoethoxydiphenyl borate (2-APB) and
bongkrekic acid (BKA) were purchased from BioMol (Plymouth
Meeting, PA). The drugs were dissolved in dimethyl sufoxide
(DMSO) as concentrated stocks for storage at -20 °C. Before use, the
stocks were diluted by at least 1000-fold with Hank's balanced salt
solution (HBSS) supplemented with bicarbonate (pH 7.4) to yield a
ﬁnal concentration of ≤0.1% DMSO, which alone had no effect on our
assays. An anti-2,4,6-trinitrophenyl (TNP) IgE monoclonal antibody
(clone IgE-3) was obtained from BD PharMingen (San Diego, CA).
TNP-BSA conjugate (TNP:BSA conjugation ratio of 25:1) was pur-
chased from Cosmo Bio (Tokyo, Japan).
2.2. RBL-2H3 cells
The RBL-2H3 cells were obtained from the National Institute of
Health Sciences (Japanese Collection of Research Bioresources, [JCRB];
Cell No. JCRB0023) and cultured in Dulbecco's modiﬁed Eagle's
medium (DMEM; Sigma-Aldrich) supplemented with 10% fetal
bovine serum (FBS; SAFC Biosciences, Tokyo, Japan) in a 5% CO2-
containing atmosphere. Cells were harvested by incubation in HBSS
(pH7.4) containing 1 mM ethylenediamine tetraacetate and 0.25%
trypsin for 5 min at 37 °C. For IgE sensitization, cells suspended in
DMEM were plated on 100-mm culture dishes (5×106 cells/5 ml) or
6-well plates (1×106 cells/well) and incubated with anti-TNP IgE
(0.1 μg) at 37 °C overnight.
2.3. Measurement of intracellular NO
Generation of intracellular NO was measured by ﬂow cytometry as
previously described [32] except that diaminoﬂuorescein-FM-diace-
tate (DAF-FM-DA) was used instead of DAF-2-DA, because it is more
sensitive for NO detection. Cells (1×106 cells/ml) suspended in Ca2+-
containing medium (HBSS supplemented with 1 mM CaCl2) were
incubated with 5 μM DAF-FM-DA for 15 min at 37 °C in a volume of
450 μL. Next, 50 μl of stimulant (10×) was added and incubated for
10min at 37 °C before harvesting. The cells werewashed, resuspended
in Ca2+-containing medium on ice, centrifuged at 4 °C, and measured
for their DAF-FM ﬂuorescence in a FACSCalibur (Becton-Dickinson,
San Jose, CA, USA) with excitation and emission at 488 and 575 nm,
respectively. The data were analyzed using the CellQuest software
(Becton-Dickinson). In inhibition experiments, the agents to be tested
were added to the cells at 15 min before stimulation.
2.4. Measurement of [Ca2]c
[Ca2+]c was measured using the Ca2+-reactive ﬂuorescent probe
Fluo3/AM as previously described [33]. Brieﬂy, a cell suspension
(1×106 cells/ml) was incubated with 4 μM Fluo3/AM for 40 min at
37 °C, washed with HBSS and resuspended in HBSS supplemented
with 1 mM CaCl2. In analyses of the effects of extracellular Ca2+,
Fluo3/AM-loaded cells were resuspended in HBSS supplementedwith
1mM EGTA instead of 1mM CaCl2. Fluorescence was monitored at 5-s
intervals for up to 3 min using a microplate ﬂuorometer (Fluoroskan
Ascent CF; Labsystems, Helsinki, Finland) with excitation and
emission at 485 and 527 nm, respectively. [Ca2+]c was calculated-
using the equation: [Ca2+]c=Kd ((F-Fmin)/(Fmax F), where Kd is the
dissociation constant of the Ca2+-Fluo3 complex (450 nM). Fmax
represents the maximum ﬂuorescence (obtained by treating cells
with 5 μM A23187), and Fmin represents the minimum ﬂuorescence
(obtained by treating cells with A23187 in the presence of 10 mM
EGTA). F is the actual sample ﬂuorescence.
2.5. Analysis of the expression of NOS transcripts
Total RNAwas isolated from1×106 cells using ISOGEN (NipponGene,
Tokyo, Japan) and reverse-transcribed into cDNAs using SuperScript™ II
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gen) and 0.5 mM dNTP Mixture (Invitrogen). The neuronal NOS (nNOS),
inducible NOS (iNOS), eNOS, actin and glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) mRNA levels were measured by RT-PCR usingFig. 1. NOS-dependent NO generation is speciﬁcally required for Ag-induced Ca2+ inﬂux. (A
IgE-sensitized cells were incubated with 4 μM Fluo3/AM for 40 min, washed and resuspende
loaded cells were incubated with or without 10 or 100 μM amino-BH4 (A), 10 or 100 μM L-N
TNP-BSA (Ag). (D) Summarized data of A–C. The data are expressed as percentages of the m
means±SE of six independent experiments. ⁎pb0.05; ⁎⁎pb0.01; ⁎⁎⁎pb0.001 vs. control c
amino-BH4 (E), 10 or 100 μM L-NAME (F) or 100 μMPTIO (G) and stimulated with 1 μMTg. T
3 min in a microplate ﬂuorometer. (H) Summarized data of (E–G). The data are expressed
100%) and represent the means±SE of three independent experiments.a Model PC-802 Thermal Cycler (Astec Corporation, Fukuoka, Japan). The
primers used were as follows: nNOS, 5′-CCTTGGTAGACCTCAGC-
TATGA-3′ and 5′-TTGCCATCGAGGTCTCTGTCCA-3′; iNOS, 5′-ACAACAG-
GAACCTACCAGCTCA-3′ and 5′-GATGTTGTAGCGCTGTGTGTCA-3′; eNOS,–C) Cells (1× 106 cells/ml) were passively sensitized with anti-TNP IgE overnight. The
d in Ca2+-containing medium (HBSS supplemented with 1 mM CaCl2). The Fluo3/AM-
AME (B) or 100 μM carboxy-PTIO (PTIO; C), and immediately stimulated with 30 ng/ml
aximal [Ca2+]c in control cells stimulated with Ag alone (set at 100%) and represent the
ells (E–G). The Fluo3/AM-loaded cells were incubated with or without 10 or 100 μM
he stimulated cells were measured for their Fluo-3 ﬂuorescence at 5-s intervals for up to
as percentages of the maximal [Ca2+]c in control cells stimulated with Ag alone (set at
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GAAC-3′; β-actin, 5′-GTCACCAACTGGGACGATATG-3′ and 5′-ACCGTCA
GGCAGCTCATAGC-3′; GAPDH, 5′-ACCACAGTCCATGCCATCAC-3′ and 5′-
TCCACCACCCTGTTGCTGTA-3′. The PCR ampliﬁcations were performed
for 30 cycles of 1 min at 95 °C for denaturation, 1 min at 60 °C for
annealing and 2 min at 72 °C for extension.
2.6. siRNA knockdown of eNOS expression
Targeted siRNAs for eNOS, GAPDH and a negative control
scrambled small-interfering RNA (siRNA) with an irrelevant sequence
were purchased from Ambion (Austin, TX). Adherent cells in 6-well
plates (2.5×105 cells/well) or 24-well plates (5.0×104 cells/well)
were transfected with each siRNA (ﬁnal concentration, 5 nM) for 48 h
using the siPORT™ NeoFX transfection agent (Ambion), according to
the manufacturer's instructions. The efﬁcacy of knockdown for gene
expression was evaluated by RT-PCR analysis as described above.
2.7. siRNA knockdown of Cav1.2 LTCC α1C expression
The expression of the Cav1.2 LTCCα1C subunit was analyzed by RT-
PCR and knocked down by expression of a speciﬁc siRNA as previously
described [30].
2.8. Evaluation of cell death
Apoptotic cell death and overall cell deathwere evaluated by double-
staining with ﬂuorescein isothiocyanate (FITC)-conjugated annexin V
and propidium iodide (PI) as previously described [32]. Brieﬂy, adherent
cells in 24-well plates (5×105/well)were treatedwith the inhibitor tobeFig. 2.NOS-dependent NO generation is required for non-SOC activity, but not SOC activity. (A
with 1mMEGTA) and treated with 2 μMTg for 10min to deplete intracellular Ca2+ stores and
100 μM amino-BH4, followed by immediate addition of 2 mM CaCl2 (vertical arrow) and
Summarized data of A. The data are expressed as percentages of the maximal [Ca2+]c in cont
independent experiments. ⁎⁎⁎pb0.001 vs. control; NS: not signiﬁcant vs. control. (C) Th
(HBSS supplemented with 1mM EGTA) and treated with 2 μMTg at 37 °C for 10min to deple
in Ca2+-containing medium (HBSS supplemented with 1 mM CaCl2). The Ca2 store-depleted
with Ag andmeasured for their Fluo3 ﬂuorescence using amicroplate ﬂuorometer. The data s
Summarized data of C. The data are expressed as percentages of the maximal [Ca2+]c in co
independent experiments. ⁎⁎⁎pb0.001 vs. control.tested in DMEM containing 10% FBS and then stimulated for 18–22 h.
Phosphatidylserine (PS) that translocated from the inner to the outer
leaﬂet of theplasmamembranewasdetectedbyannexinV stainingusing
a commercially available kit (Annexin V FITC Apoptosis Detection Kit I:
BD PharMingen), according to the manufacturer's instructions. By
double-staining the cells with annexin V-FITC and PI, the subsets of
cells that were annexin V+PI-(apoptotic) and annexin V+PI+ (necrotic
and/or advanced apoptotic cells) were determined. Double-negative
cellswereconsidered tobe living cells. The stainedcellswereevaluated in
a FACSCalibur and the data were analyzed using the CellQuest software.
2.9. Measurements of caspase-3/7 activation and the Δψm
Activation of caspase-3/7 and changes in the mitochondrial
membrane potential (Δψm) were simultaneously measured as
previously described [32]. Brieﬂy, cells plated on 24-well plates
(5×105 cells/well) were washed and treated with the agent to be
tested in DMEM containing 10% FBS for 18 h. The cells were stained
with the dual sensor MitoCaspTM (Cell Technology Inc., Mountain
View, CA) according to the manufacturer's protocol. Caspase-3/7
activation and the Δψm were evaluated using a FACSCalibur and the
data were analyzed using the CellQuest software.
2.10. Cytochrome c release assay
Cytochrome c releasewasmeasured as previously described [31,32].
Brieﬂy, adherent cells in 6-well plates (3×106 cells/well)werewashed,
treatedwith the inhibitor to be tested in DMEM containing 10% FBS and
stimulated with Ag for 18 h. To assess the cytochrome c content in the
mitochondria, the cells were fractionated into mitochondrial and) Fluo3/AM-loaded cells were resuspended in Ca2+-free medium (HBSS supplemented
activate SOCs. The cells (1×106 cells/ml) were treated with or without 10 μM2-APB or
measured for their Fluo3 ﬂuorescence up to 3 min in a microplate ﬂuorometer. (B)
rol cells stimulated with Ca2+ alone (set at 100%) and represent the means±SE of four
e Fluo3/AM-loaded cells (1×106 cells/ml) were resuspended in Ca2+-free medium
te the ER Ca2 stores. After extensive washing, the store-depleted cells were resuspended
cells were treated with 100 μM amino-BH4 or 1 μM nifedipine, immediately stimulated
hown as the calculated [Ca2+]c are representative of four independent experiments. (D)
ntrol cells stimulated with Ag alone (set at 100%) and represent the means±SE of six
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isolation kit (Pierce, Rockford, IL) and the mitochondrial fraction was
lysed with 1% Triton X-100. The cytochrome c contents in the fractions
were determined using a commercially available solid-phase sandwich
ELISA kit (cytochrome c, mouse/rat, ELISA Kit, Quantikine M®; R&D
Systems, Minneapolis, MN), according to the manufacturer's protocols.
2.11. Statistical analysis
Data were analyzed by one-way ANOVAwith application of a post-
hoc Tukey test. Values of pb0.05 were considered signiﬁcant.
3. Results
3.1. NOS-dependent NO generation is speciﬁcally required for
Ag-induced Ca2+ inﬂux
We previously demonstrated that Ag, but not Tg, induces NO
generation in RBL-2H3 cells and BMMCs in a NOS-dependent manner
[32]. Elevation of [Ca2+]c is one of the earliest events observed followingFig. 3. RBL-2H3 cells only express eNOS as a constitutively expressed NOS isoform and eNOS
isolated from RBL-2H3 cells, and the amounts of nNOS, iNOS, eNOS and actin transcripts wer
Cells in 6-well plates (1×106 cells/well) were individually transfected with siRNAs for eNOS
no sequence homology to any known gene sequences was used. The expressions of eNOS and
the bands were quantitated using SCION image software. (C) Summarized data of B. The data
means±SE of ﬁve independent experiments. ***p 0.001 (below 0.001) (D–F) Control cells a
5 μM DAF-FM-DA for 15 min at 37 °C and washed. (D) The DAF-FM-DA-loaded cells (5×105
stimulated with Ag for 10 min at 37 °C. (E, F) The DAF-FM-DA-loaded cells were stimulated w
WT (E). After washing, the cells were immediately resuspended in HBSS on ice and mea
ﬂuorescence ratios (F/F0), where F0 is the ﬂuorescence in unstimulated cells and F is th
experiments. ⁎⁎pb 0.01; ⁎⁎⁎pb0.001, NS: not signiﬁcant.activation of FcɛRI, which plays critical roles in the signal transduction
pathways that lead to degranulation, LTC4 secretion and cytokine
production. Therefore, we examined the possible role of the generated
NOinCa2+signalingusingRBL-2H3cells as amodel. Consistentwithour
previous ﬁndings [32], Ag stimulation of IgE-sensitized cells resulted in
substantial NO generation, asmeasuredwith theNO-sensitive dye DAF-
FM-DA and amino-BH4 at concentrations of 10 and 100 μM reduced the
NO generation by 50% and 75%, respectively (see Fig. 3D). Amino-BH4
competes with H4-biopterin, the natural cofactor of NOS activity,
thereby inhibiting the activities of all NOS isoforms [34,35]. As shown
in Fig. 1A, robust elevation of [Ca2+]c was observed after Ag
stimulation, and pretreatment of the cells with amino-BH4 at
concentrations of ≥10 μM dose-dependently reduced the [Ca2+]c
elevation with selective blockade of the relatively early phase (until
2min) (Fig. 1A andD).Moreover, the arginine-competingNOS inhibitor
L-NAME at concentrations of ≥10 μM (Fig. 1B and D) and 100 μM
carboxy-PTIO, aNO-selective scavenger reduced theAg-induced [Ca2+]c
elevation (Fig. 1C and D). On the contrary, amino-BH4, L-NAME and
carboxy-PTIO at concentrations of up to 100 μMhadminimal effects on
Tg-induced [Ca2+]c elevation (Fig. 1E–H). These results show that NOS-is responsible for the Ca2+- and PI3K-dependent NO generation. (A, B) Total RNAs were
e analyzed by RT-PCR. The data are representative of ﬁve independent experiments. (B)
and GAPDH. As a negative control siRNA (Nega), a nontargeting scrambled siRNA with
GAPDHwere analyzed by RT-PCR at 48 h after the siRNA transfection. The intensities of
are expressed relative intensity (the intensity of control is set at 1.0) and represent the
nd eNOS knocked down cells were passively sensitized with anti-TNP IgE, loaded with
cells/450 μl) were resuspended in Ca2+-containing medium or Ca2+-free medium and
ith Ag for 10min at 37 °C with or without 10 or 100 μM amino-BH4 (D) or 10 or 100 nM
sured for their DAF-FM ﬂuorescence by ﬂow cytometry. The data are shown as the
e ﬂuorescence in stimulated cells, and represent the means±SE of six independent
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inﬂux.
3.2. NOS-dependent NO generation is required for non-SOC activity but
not SOC activity
Given that Tg is a potent activator of SOCs, including CRAC
channels [6-8], the data described above suggest that NOS-dependentFig. 4. eNOS is required for Ag-induced Ca2+ inﬂux, but not Tg-induced Ca2+ inﬂux or CRAC ch
were sensitized with IgE, loaded with Fluo3/AM, washed and resuspended in Ca2+-containing
Fluo3/AM-loaded cellswere incubatedwith orwithout 100 μMamino-BH4 and immediately sti
maximal [Ca2+]c in control cells stimulated with Ag alone (set at 100%) and represent the m
signiﬁcant. (D) The Fluo3-loaded cells were directly stimulatedwith 1 μMTg and thenmeasure
data of D. Thedata are expressed as percentages of themaximal [Ca2+]c in control cells stimulate
The Fluo3/AM-loaded cells were resuspended in Ca2+-free medium (HBSS supplemented with
activate SOCs. The cells (1×106 cells/ml) were treated with 2 mM CaCl2 (vertical arrow) and
Summarized data of E. The data are expressed as percentages of themaximal [Ca2+]c in control c
experiments.NO generation plays minor roles in SOC activity. To examine this
hypothesis, we determined the effects of NOS inhibitors on SOC
activity. To speciﬁcally activate SOCs, we employed the classical Ca2+-
readdition protocol. Brieﬂy, cells were treated with Tg in Ca2+-free
medium to deplete the ER Ca2+ stores and Ca2+ was then re-added.
This resulted in a robust Ca2+ inﬂux, which was completely blocked by
pretreatmentwith 2-APB, a SOC antagonist (Fig. 2A and B). On the other
hand, amino-BH4 (Fig. 2A and B) and the arginine-competing NOSannel activity. (A, B) Control cells (A) and eNOS knocked down cells (1×106 cells/ml) (B)
medium (HBSS supplemented with 1 mM CaCl2) as described in the legend for Fig. 1. The
mulatedwith Ag. (C) Summarized data of A, B. Thedata are expressed as percentages of the
eans±SE of ﬁve independent experiments. **p 0.01 (below 0.01)⁎⁎⁎ pb0.001; NS: not
d for their Fluo-3ﬂuorescence for up to 3min in amicroplateﬂuorometer. (F) Summarized
dwith Tg (set at 100%) and represent themeans±SEofﬁve independent experiments. (E)
1 mM EGTA) and treated with 2 μM Tg for 10 min to deplete intracellular Ca2 stores and
measured for their Fluo3 ﬂuorescence for up to 3 min in a microplate ﬂuorometer. (G)
ells stimulatedwith Ca2+ (set at 100%) and represent themeans±SE of four independent
Fig. 5. eNOS is required for Cav1.2 LTCC activity. (A–F) Control cells (A, D) eNOS knocked down cells (B, E) andα1C-knocked down cells (C, F) were sensitized with IgE and loaded with Fuo3/AM as described in the legend for Fig. 1. The Fluo3/
AM-loaded cells (1×106 cells/ml) were resuspended in Ca2+-free medium (HBSS supplemented with 1 mM EGTA) and treated with 2 μM Tg at 37 °C for 10 min to deplete the ER Ca2+ stores. After extensive washing, the store-depleted cells
were resuspended in Ca2+-containing medium (HBSS supplemented with 1 mM CaCl2). The Ca2+ store-depleted cells (1×106 cells/ml) were resuspended in Ca2+-containing medium (HBSS supplemented with 1 mM CaCl2), treated with
100 μM amino-BH4 or 100 nMWT (A–C) or 1 μM nifedipine (D–F), immediately stimulated with Ag and measured for their Fluo3 ﬂuorescence using a microplate ﬂuorometer. (G) Fig. 5G was completely lost. Summarized data of (A-F). The
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up to 100 μM had minimal effects on the Ca2+ inﬂux. We recently
demonstrated that Ag, but not Tg, induced DHP-sensitive Ca2+ inﬂuxes
independently of Ca2+ store emptying and identiﬁed Cav1.2 LTCCs as
one of the non-SOCs in mast cells [30,36]. Therefore, we examined
whether NO affects this kind of Ca2+ channel. As shown in Fig. 2C,
pretreatmentwith amino-BH4 strongly reduced the non-SOC activity at
concentrations that blocked the NO generation. The effects of amino-
BH4 were comparable to those of nifedipine (Fig. 2C and D). Taken
together, these results show that NOS-dependent NO generation is
necessary for non-SOC activity but not SOC activity.
3.3. eNOS is responsible for the Ag-induced NO generation
Our previous study [32] revealed that Ag-induced NO generation
in mast cells is strictly dependent on extracellular Ca2+, suggesting
that it is mediated by constitutively expressed NOS isoforms such as
eNOS and nNOS. Moreover, the NO generation was accompanied by
increased phosphorylation of eNOS at Ser1177, an important
mechanism for increasing eNOS activity [37,38] and increased
phosphorylation of Akt at Ser473, the residue linked to eNOS
activation [39,40]. These observations strongly suggested that eNOS
plays a role in the Ag-induced NO generation. To obtain more direct
evidence for the role of eNOS, we analyzed expression levels of NOS
isoforms by RT-PCR. As shown in Fig. 3A, a substantial amount of eNOS
expression was observed with lower expression of iNOS, while
expression of nNOS was not observed. These data clearly demonstrateFig. 6. eNOS is essential for the survival of Ag-activated cells. (A) Adherent IgE-sensitized
treated with or without 100 μM amino-BH4 and then stimulated with Ag or 1 μM Tg for 18 h
annexin V and PI. Double-negative cells were considered to be living cells. (B, C) Summarized
for control cells (B) and eNOS knocked down cells (C). The data represent the means±SEthat eNOS in is the major constitutive NOS isoform expressed in the
cells. To further demonstrate the role of eNOS in the Ag-induced NO
generation, we examined the effects of knockdown of eNOS
expression on the NO generation. As shown in Fig. 3B and C,
transfection of a siRNA speciﬁc for eNOS resulted in a robust decrease
in eNOSmRNA expression. The eNOS knockdown had aminimal effect
on GAPDH expression, thereby verifying its speciﬁcity. Next, we
compared the NO generation between control cells and eNOS knocked
down cells. To clarify the role of eNOS in Ca2+-dependent NOS
activity, wemeasured Ag-stimulated NO generation in the presence or
absence of extracellular Ca2+. Compared with control cells, eNOS
knocked down cells exhibited signiﬁcantly decreased Ca2+-depen-
dent NOS activity (80% reduction), while Ca2+-independent NOS
activity was minimally affected (Fig. 3D). The decrease in Ca2+-
dependent NOS activity was accompanied by marked reductions in
the inhibitory effects of amino-BH4 andWT (Fig. 3E and F). These data
demonstrate that eNOS is responsible for the Ag-stimulated NO
generation.
3.4. eNOS is required for Cav1.2 LTCC activity
To demonstrate the role of eNOS in Ag-induced Ca2+ signaling,
we compared the Ca2+ signaling between control cells and eNOS
knocked down cells. Compared with control cells, a substantial
reduction in [Ca2+]c elevation was observed in eNOS knocked down
cells (Fig. 4A–C). Moreover, unlike control cells, the Ca2+ signals
were minimally affected by pretreatment with amino-BH4 atcontrol cells and eNOS knocked down cells in 24-well plates (5×105 cells/well) were
at 37 °C. Apoptotic cell death was evaluated by double-staining with FITC-conjugated
data of the ratios of annexin V-positive cells in experimental groups vs. control groups
of six independent experiments. ⁎⁎⁎pb 0.001.
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NOS-dependent Ca2+ signals. There were minimal differences in Tg-
induced [Ca2+]c elevation (Fig. 4D and F) and CRAC channel activity
between the two cell types (Fig. 4E and G). These data clearly
demonstrate that eNOS is responsible for the NOS-dependent Ca2+
signals. Since the data described above suggest that NOS-dependent
NO generation is required for a non-SOC activity, but not SOC
activity, we hypothesized that eNOS is required for the non-SOC
activity. As expected, a substantial reduction in Ca2+ inﬂux
(maximum of 80% reduction) was observed in eNOS knocked
down cells compared with control cells (Fig. 5A, B and G). Moreover,
unlike control cells, the Ca2+ inﬂux was minimally affected by
pretreatment with amino-BH4 and WT at concentrations of up to
100 μM (Fig. 5B and G), indicating the independence of the NOS and
PI3K activities. Recently, we reported that Cav1.2 LTCCs comprise a
major LTCC subtype expressed in mast cells and are involved in Ag-
activated DHP-sensitive non-SOC activity [30,36]. Nifedipine sub-
stantially reduced the non-SOC activity in control cells but not in
eNOS knocked down cells (Fig. 5D, E and G), indicating that eNOS
mediates the DHP-sensitivity. To more directly demonstrate the link
between eNOS and Cav1.2 LTCCs, we simultaneously measured Ca2+
entry into the α1C-knocked down cells, in which the expression of
the Cav1.2 LTCC α1C subunit is depleted at the mRNA and protein
levels [30]. Compared with control cells, a robust reduction in theFig. 7. eNOS is essential for themaintenance of mitochondrial integrity in Ag-activated cells. (
(5×105 cells/well) were stimulated with Ag or 1 μM Tg for 18 h at 37 °C in the presence o
determined as described in Materials and methods. The data are representative of six indepe
experimental groups vs. control groups for control cells (B) and eNOS knocked down cells (C
signiﬁcant.non-SOC activity was also observed in α1C-knocked down cells.
Strikingly, the levels of the reduction in the non-SOC activity were
comparable between eNOS knocked down cells and α1C-knocked
down cells (Fig. 5G). Moreover, unlike control cells, the non-SOC
activity was minimally affected by pretreatment with amino-BH4
and WT as well as nifedipine (Fig. 5C, F and G). Taken together,
these data demonstrate that eNOS is required for Cav1.2 LTCC
activity.
3.5. eNOS is essential for the survival of Ag-activated cells
Our previous pharmacological and genetic experiments revealed
that Cav1.2 LTCCs protect mast cells against Ag-induced cell death
[31]. Therefore, we investigated the role of eNOS in cell survival. After
18-22 h of culture, control cells and eNOS knocked down cells were
analyzed for PS externalization and PI staining. Although it has been
reported that mast cell degranulation results in PS externalization in
the absence of apoptosis [41], substantial degranulation but minimal
PS externalization have been observed following Ag stimulation of
RBL-2H3 cells [42]. Moreover, galectin-3 does not induce any
signiﬁcant degranulation at concentrations that effectively induce PS
externalization [42]. These data exclude the possibility that the PS
externalization observed in the present study is a result of
degranulation and validate that PS externalization can serve as aA) Adherent IgE-sensitized control cells and eNOS knocked down cells in 24-well plates
r absence of 100 μM amino-BH4. Caspase-3/7 activation and changes in the Δψm were
ndent experiments. (B, C) Summarized data of the ratios of caspase-3/7-positive cells in
). The data represent themeans±SE of six independent experiments. ⁎⁎pb0.01; NS: not
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types incubated with the vehicle were similar (N95%) (Fig. 6A, panels
a and e), indicating that eNOS had a minimal effect on cell survival in
the resting state, as observed for Cav1.2 LTCCs [31]. After Ag
stimulation, eNOS knocked down cells underwent considerable
apoptosis, which was comparable to that observed in control cells
stimulated with amino-BH4 + Ag (Fig. 6A, panels c and f). Amino-BH4
alone has minimal effects on the cell viability [32]. On the contrary,
the absence of eNOS had minimal effects on Tg-induced apoptosis
(Fig. 6A, panels d and h). Summarized data for control cells and eNOS
knocked down cells in six independent experiments are shown in Fig.
6B and 6C, respectively. Taken together, these results demonstrate
that eNOS is essential for the survival of Ag-activated cells.
3.6. eNOS prevents mitochondrial integrity disruption by modulating
mPTP opening
The mitochondrial apoptotic pathway is the major death pathway,
in which mitochondria act as central gateway controllers through the
release of a number of apoptogenic factors, including cytochrome c,
into the cytoplasm. The collapse of Δψm leads to mitochondrial
integrity disruption and cytochrome c release, which in turn leads to
the activation of caspase cascade pathways. Consequently, the
prevention of these processes leads to cell survival. In fact, we
previously reported that Cav1.2 LTCCs prevent mitochondrial integrity
disruption in mast cells [31]. To examine whether eNOS exhibits
similar pro-survival effects, we compared the cellular susceptibilitiesFig. 8. eNOS prevents Ag-induced apoptosis by modulating mPTP opening. (A) Adherent IgE
well) were treated with or without 100 μM amino-BH4, 10 μM z-DEVD-fmk (z-DEVD) and
evaluated by double-staining with FITC-conjugated annexin V and PI. (B, C) Summarized da
control cells (B) and eNOS knocked down cells (C). The data represent the means±SE of sto Δψm collapse, caspase-3/7 activation and cytochrome c release
between control cells and eNOS knocked down cells. In the resting
state, minimal Δψm collapse and caspase-3/7 activation were
observed in the two cell types (Fig. 7A, panels a and e), indicating
that eNOS plays minor roles in these two events in the resting state.
However, after Ag stimulation, substantial Δψm collapse and caspase-
3/7 activation occurred in eNOS knocked down cells, whichwere both
comparable to those observed in control cells stimulated with amino-
BH4 + Ag (Fig. 7A, panels c and f). Amino-BH4 alone induces minimal
Δψm collapse and caspase-3/7 activation [32]. Summarized data for
control cells and eNOS knocked down cells in three independent
experiments are shown in Fig. 7B and C, respectively. Moreover, z-
DEVD-fmk, a speciﬁc inhibitor of caspase-3/7, blocked amino-BH4 +
Ag-induced apoptosis in control cells as well as Ag-induced apoptosis
in eNOS knocked down cells (Fig. 8A, panels c and g), indicating
critical roles for activation of caspase cascade pathways in the induced
apoptosis. Strikingly, BKA, an mitochondrial permeability transition
pore (mPTP) antagonist, also completely blocked the apoptosis as well
as mitochondrial depolarization and caspase-3/7 activation in the two
cell types (Fig. 9A, panels d and h). After Ag stimulation, no signiﬁcant
changes in the cytosolic and mitochondrial cytochrome c contents
were observed in control cells, while a substantial increase in the
cytosolic cytochrome c content in parallel with a decrease in the
mitochondrial cytochrome c content were observed in eNOS knocked
down cells (Fig. 10A). The magnitude of the cytochrome c release was
comparable to that observed in control cells stimulated with amino-
BH4 + Ag (Fig. 10B). Moreover, BKA blocked the cytochrome c-sensitized control cells and eNOS knocked down cells in 24-well plates (5×105 cells/
/or 1 μM BKA and then stimulated with Ag for 18 h at 37 °C. Apoptotic cell death was
ta of the ratios of annexin V-positive cells in experimental groups vs. control groups for
ix independent experiments. ⁎⁎⁎pb0.001.
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together, these results demonstrate that eNOS prevents mitochon-
drial integrity disruption via mPTP modulation.
4. Discussion
It has been shown that NO suppresses mast cell effector functions,
including degranulation, LT secretion and cytokine expression and
release [43,44]. However, there is controversy regarding the gener-
ation of NO by mast cells and its autocrine effects. Several studies
using RT-PCR, immunoblotting, immunostaining or confocal micros-
copy have demonstrated that rodent and human mast cells express
nNOS, iNOS and eNOS and generate NO themselves [45–49]. On the
contrary, Swindle et al. reported that rodent and human mast cells do
not express iNOS (nNOS and eNOS were not studied) or generate NO
[50]. It is speculated that this discrepancy arises at least partly through
strain differences in NOS expression and NO generation by mast cells
[45]. Speciﬁcally, Swindle et al. [50] used peritoneal mast cells from
Brown Norway rats, whereas most of the other studies used
peritoneal mast cells from Sprague–Dawley (SD) rats. Parallel
experiments using peritoneal mast cells revealed that iNOS mRNA
expression and NO generation are much lower in mast cells from BNFig. 9. eNOS prevents Ag-induced caspase-3/7 activation and the collapse of Δψm by modula
cells in 24-well plates (5×105 cells/well) were stimulated with Ag for 18 h at 37 °C in the pre
and analyzed for caspase-3/7 activation and changes in the Δψm. The data are representativ
positive cells in experimental groups vs. control groups for control cells (B) and eNOS knock
⁎pb0.05; ⁎⁎pb0.01.rats than in mast cells from SD rats [45]. Therefore, it is becoming
increasingly evident that mast cells themselves express NOS and
generate NO. To date, however, there has been no direct evidence that
mast cells generate NO via NOS activity. We previously reported that
upon Ag stimulation causes RBL-2H3 mast cells and BMMCs to
generate substantial levels of NO and that this NO generation is largely
dependent on NOS activity [32]. The NO generation occurs via PI3K
activation and extracellular Ca2+ entry and is accompanied by
increased phosphorylations of eNOS at Ser1177 and Akt at Ser473,
both of which are reduced by WT. Therefore, the NO generation is
most likely to occur via the PI3K-Akt-eNOS pathway. In an expansion
of our previous study, we found that RBL-2H3 cells only express eNOS
as a constitutively expressed NOS isoform in the present study.
Moreover, experiments using eNOS knocked down cells clearly
demonstrated that eNOS was responsible for the PI3K- and Ca2+-
dependent NO generation. Strikingly, Ag-induced NO generation
exhibited varying Ca2+ dependencies depending on the timing of the
measurements. At early time points (e.g., 5–10 min), the NO
generation is largely (approximately 80%) dependent on extracellular
Ca2+, while at later time points (e.g., 30 min) it predominantly occurs
independently of extracellular Ca2+, although it is still PI3K-
dependent [32]. Therefore, unlike the early NO generation, the sourceting mPTP opening. (A) Adherent IgE-sensitized control cells and eNOS knocked down
sence or absence of 100 μMamino-BH4, 10 μM z-DEVD-fmk (z-DEVD) and/or 1 μMBKA,
e of six independent experiments. (B, C) Summarized data of the ratios of caspase-3/7-
ed down cells (C). The data represent the means±SE of six independent experiments.
Fig. 10. eNOS prevents Ag-induced cytochrome c release by modulating mPTP opening.
(A–C) Adherent IgE-sensitized control cells (A, B) and eNOS knocked down cells (A, C)
in 6-well plates (3×106 cells/well) were stimulated with Ag for 18 h at 37 °C in the
presence or absence of 100 μMamino-BH4 and/or 1 μMBKA. The cells were fractionated
into cytosolic and mitochondrial fractions by differential centrifugation, and the
cytochrome c contents in the fractions were determined using an ELISA kit. The data
represent the means±SE of six independent experiments. ⁎⁎pb0.01; ⁎⁎⁎pb0.001; NS:
not signiﬁcant.
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expression and NO generation are up-regulated by FcɛRI engagement
and stem cell factor in the different subsets of mast cells [46].
Consistent with that report, we detected a smaller extent of iNOS
expression in RBL-2H3 cells in the present study. Collectively, it is
possible that mast cells generate NO via eNOS and iNOS at different
time points after FcɛRI engagement.
Another important ﬁnding obtained in the present study is that NO
is essential for Cav1.2 LTCC activity, whereas it plays minor roles in
CRAC channel activity. Blockade of NO generation and knockdown of
eNOS expression substantially reduced Ag-induced Ca2+ inﬂux and
Cav1.2 LTCC activity, but had minimal effects on Tg-induced Ca2 inﬂux
and CRAC channel activity. Importantly, knockdown of eNOS
expression exhibited effects that were comparable to knockdown of
the Cav1.2 LTCC α1C subunit. Given that eNOS mediates Ag-induced
NO generation, these ﬁndings demonstrate that NO generated by
eNOS mediates Cav1.2 LTCC activity. It is widely accepted that SOCE
mediated by SOCs such as CRAC channels is the main mode of Ca2+
inﬂux into non-excitable cells such as hematopoietic cells. However,
the emerging view is that various hematopoietic cells such as B cells[20,21], dendritic cells [22,23], NK cells [24], neutrophils [25] and T
cells [26–29], express functional LTCC and/or LTCC-like channels,
which are activated by Ag receptor stimulation. In agreement with
this view, we previously reported that mast cells express Cav1.2
LTCCs, which are activated by FcɛRI engagement [30]. However, the
activation mechanisms of this kind of channel remain unclear, since
unlike excitable cells, membrane depolarization by high K+ loading
alone does not evoke any Ca2+ inﬂux in these hematopoietic cells. The
data described in the present study clearly demonstrate that NO
generated by eNOS mediates Cav1.2 LTCC activation. These ﬁndings
are consistent with our previous ﬁndings that Ag, but not Tg, induces
NOS-dependent NO generation [32] and Cav1.2 LTCC activation [30].
Importantly, our previous study revealed that Ag evokes substantial
membrane depolarization followed by repolarization, while Tg
induces membrane hyperpolarization in a sustained manner. The
membrane potential usually returns to the basal levels within 3 min
after FcɛRI engagement [30]. In the present study, NO blockade or
eNOS knockdown signiﬁcantly reduced Ca2+ inﬂux until that time
point, suggesting that Cav1.2 LTCCs are the major route of the Ca2+
inﬂux. Since membrane polarization is a powerful driving force for
CRAC channel activity, while membrane depolarization leads to
opening of LTCCs, the membrane potential condition must be a
critical factor in determining which channels are preferentially
activated in a given cell. Moreover, high K+ loading alone can evoke
substantial Ca2+ inﬂux, thereby increasing [Ca2+]c and [Ca2+]m in the
ER Ca2+ store-depleted cells [30,31], suggesting that the Ca2+ store
status also modulates the function of Cav channels. Collectively, it is
possible that the activation of LTCCs in mast cells and possibly in other
hematopoietic cells is regulated by multiple cellular physiological
parameters, including the membrane potential, ER Ca2 store condi-
tions and NO level, although further investigations are necessary to
establish this view.
One of the most attractive properties of Cav1.2 LTCCs is their pro-
survival function. Our previous study revealed that Cav1.2 LTCCs
protect mast cells against Ag-induced activation-induced cell death by
preventing mitochondrial integrity collapse, the major cause of the
mitochondrial cell death pathway [31]. Strikingly, we also found that
NOS-dependent NO is necessary for the maintenance of the
mitochondrial integrity, thereby exhibiting a pro-survival function
[32]. As described above, the present study revealed that eNOS
mediates Ag-induced NO generation and that NO generated by eNOS
mediates Cav1.2 LTCC activity, thereby demonstrating an essential
role for the eNOS-NO-Cav1.2 LTCC axis in mast cell survival.
Importantly, knockdown of the expression of Cav1.2 LTCCs [31] or
eNOS (present study) expression has minimal effects on mast cell
survival in the resting state. These observations suggest that the
eNOS-NO-Cav1.2 LTCC axis plays a role in mast cell survival after cell
activation. Given that eNOS is activated by the PI3K-Akt pathway [32],
it is the most likely that FcɛRI delivers a pro-survival signal by evoking
PI3K-Akt-dependent eNOS phosphorylation and NO generation,
which in turn stimulates Cav1.2 LTCC activity. Interestingly, both the
PI3K-Akt pathway and eNOS have been shown to play key roles in the
survival of various cells, including NK cells and vascular endothelial
cells [51–54]. It is noteworthy that the absence of eNOS and Cav1.2
LTCCs was completely compensated by the presence of BKA and z-
DEVD-fmk, a caspase-3/7-selective inhibitor, which block mPTP
opening and the downstream caspase cascade pathway, respectively.
These data strongly suggest that the eNOS-NO-Cav1.2 LTCCs axis is a
physiological regulator of the mPTPs.
In conclusion, the data described in the present study reveal the
existence of an eNOS-NO-Cav1.2 LTCCs axis, which plays a critical role
in the maintenance of mitochondrial integrity by negatively regulat-
ing mPTP opening after FcɛRI engagement. A model for the eNOS-NO-
Cav1.2 LTCCs axis in mast cell survival is shown in Fig. 11. To the best
of our knowledge, this is also the ﬁrst study to unveil the molecular
basis of LTCC activation in hematopoietic cells. Further studies
Fig. 11.Model for the role of the eNOS-NO-Cav1.2 LTCCs axis in mast cell survival. Ag cross-linking of IgE-bound FcɛRI results in depletion of the ER Ca2 stores followed by activation
of SOC channels such as CRAC channels. FcɛRI cross-linking also results in a PI3K-dependent activation of eNOS and the generation of intracellular NO, which in turn leads to
activation of Cav1.2 LTCCs. The activation of Cav1.2 LTCCs primarily causes Ca2 entry into the mitochondria, although under certain conditions it appears to cause substantial Ca2
inﬂux into the cytosol. The Ca2 entering into the mitochondria prevent the collapse of Δψm and the mPTP-mediated cytochrome c release, thereby protecting mast cells against
caspase cascade activation and apoptosis. Therefore, the eNOS-NO-Cav1.2 LTCC axis plays key roles in the maintenance of mitochondrial integrity and is essential for mast cell
survival following FcɛRI cross-linking.
384 Y. Suzuki et al. / Biochimica et Biophysica Acta 1803 (2010) 372–385attempting to clarify the molecular mechanisms underlying the NO-
mediated regulation of LTCC activation and LTCC-mediated regulation
of mitochondrial integrity are underway.
Acknowledgements
We thank the National Institute of Health Sciences (Japanese
Collection of Research Bioresources) for providing the RBL-2H3 cell
line (cell number JCRB0023). We thank Dr. T. Yoshimaru for his
excellent technical assistance. This work was partially supported by a
grant-in-aid from the High-Tech Research Center Project (2003–
2007) for Private Universities: matching fund subsidy from MEXT, a
grant-in-aid from MEXT (matching fund subsidy for Private Univer-
sities 2007–2009) and by grants-in-aid from Nihon University.
References
[1] A.B. Parekh, R. Penner, Store depletion and calcium inﬂux, Physiol. Rev. 77 (1997)
901–930.
[2] A.B. Parekh, J.W. Putney Jr., Store-operated calcium channels, Physiol. Rev. 85
(2005) 757–810.
[3] G.J. Barritt, Receptor-activated Ca2+ inﬂow in animal cells: a variety of pathways
tailored to meet different intracellular Ca2+ signaling requirements, Biochem. J.
337 (1999) 153–169.
[4] A.C. Elliott, Recent developments in non-excitable cell calcium entry, Cell Calcium
30 (2001) 73–93.
[5] J.W. Putney Jr., L.M. Broad, F.J. Braun, J.P. Lievremont, G.S. Bird, Mechanisms of
capacitative calcium entry, J. Cell Sci. 114 (2001) 2223–2229.
[6] M. Montero, J. Alvarez, J. Garcia-Sancho, Uptake of Ca2+ and reﬁlling of
intracellular Ca2+ stores in Ehrlich-ascites-tumour cells and in rat thymocytes,
Biochem. J. 271 (1990) 535–540.
[7] M. Montero, J. Alvarez, J. Garcia-Sancho, Agonist-induced Ca2+ inﬂux in human
neutrophils is secondary to the emptying of intracellular calcium stores, Biochem.
J. 277 (1991) 73–79.[8] J. Alvarez, M. Montero, J. Garcia-Sancho, Agonist-induced Ca2+ inﬂux in human
neutrophils is not mediated by production of inositol polyphosphates but by
emptying of the intracellular Ca2+ stores, Biochem. Soc. Trans. 22 (1994) 809–813.
[9] M. Hoth, R. Penner, Depletion of intracellular calcium stores activates a calcium
current in mast cells, Nature 355 (1992) 353–356.
[10] A. Zweifach, R.S. Lewis, Mitogen-regulated Ca2+ current of T lymphocytes is
activated by depletion of intracellular Ca2+ stores, Proc. Natl. Acad. Sci. U. S. A. 90
(1993) 6295–6299.
[11] J.T. Smyth, W.I. Dehaven, B.F. Jones, J.C. Mercer, M. Trebak, G. Vazquez, J.W. Putney
Jr., Emerging perspectives in store-operated Ca2+ entry: roles of Orai, Stim and
TRP, Biochim. Biophys. Acta 1763 (2006) 1147–1160.
[12] S. Feske, S. Calcium signalling in lymphocyte activation and disease, Nat. Rev.,
Immunol. 7 (2007) 690–702.
[13] S.J. Galli, J. Kalesnikoff, M.A. Grimbaldeston, A.M. Piliponsky, C.M. Williams, M.
Tsai, Mast cells as “tunable” effector and immunoregulatory cells: recent
advances, Annu. Rev. Immunol. 23 (2005) 749–786.
[14] Y. Baba, K. Nishida, Y. Fujii, T. Hirano, M. Hikida, T. Kurosaki, Essential function for
the calcium sensor STIM1 in mast cell activation and anaphylactic responses, Nat.
Immunol. 9 (2008) 81–88.
[15] M. Vig, W.I. DeHaven, G.S. Bird, J.M. Billingsley, H. Wang, P.E. Rao, A.B. Hutchings,
M.H. Jouvin, J.W. Putney, J.P. Kinet, Defective mast cell effector functions in mice
lacking the CRACM1 pore subunit of store-operated calcium release-activated
calcium channels, Nat. Immunol. 9 (2008) 89–96.
[16] M. Vig, J.P. Kinet, Calcium signaling in immune cells, Nat. Immunol. 10 (2009) 21–27.
[17] T.T. Ching, A.L. Hsu, A.J. Johnson, C.S. Chen, Phosphoinositide 3-kinase facilitates
antigen-stimulated Ca2+ inﬂux in RBL-2H3 mast cells via a phosphatidylinositol
3,4,5-trisphosphate-sensitive Ca2+ entry mechanism, J. Biol. Chem. 276 (2001)
14814–14820.
[18] P. Bradding, Y. Okayama, N. Kambe, H. Saito, Ion channel gene expression in
human lung, skin, and cord blood-derived mast cells, J. Leukoc. Biol. 73 (2003)
614–620.
[19] KahrH , SchindlR , FritschR , B. Heinze, M. Hofbauer, M.E. Hack, M.A. Mörtelmaier,
K. Groschner, J.B. Peng, H. Takanaga, M.A. Hediger, C. Romanin, CaT1 knock-down
strategies fail to affect CRAC channels in mucosal-type mast cells, J. Physiol. 557
(2004) 121–132.
[20] G. Grafton, L. Stokes, K.M. Toellner, J. Gordon, A non-voltage-gated calcium
channel with L-type characteristics activated by B cell receptor ligation, Biochem.
Pharmacol. 66 (2003) 2001–2009.
[21] A.A.S. Akha, N.J. Willmott, K. Brickley, A.C. Dolphin, A. Galione, S.V. Hunt, Anti-Ig-
induced calcium inﬂux in rat B lymphocytes mediated by cGMP through a
dhydropyridine-sensitive channel, J. Biol. Chem. 271 (1996) 7297–7300.
385Y. Suzuki et al. / Biochimica et Biophysica Acta 1803 (2010) 372–385[22] A. Poggi, A. Rubartelli, M.R. Zocchi, Involvement of dihydropyridine- sensitive
calcium channels in human dendritic cell function. Competition by HIV-1 Tat,
J. Biol. Chem. 273 (1988) 7205–7209.
[23] M. Vukcevic, G.C. Spagnoli, G. Iezzi, F. Zorzato, S. Treves, Ryanodine receptor
activation by Cav1.2 is involved in dendritic cell major histocompatibility complex
class II surface expression, J. Biol. Chem. 283 (2008) 34913–34922.
[24] M.R. Zocchi, A. Rubartelli, P. Morgavi, A. Poggi, HIV-1 Tat inhibits human natural
killer cell function by blocking L-type calcium channels, J. Immunol. 161 (1998)
2938–2943.
[25] C. Rosales, E.J. Brown, Calcium channel blockers nifedipine and diltiazem inhibit
Ca2+ release from intracellular stores in neutrophils, J. Biol. Chem. 267 (1992)
1443–1448.
[26] M.F. Kotturi, D.A. Carlow, J.C. Lee, H.J. Ziltener, W.A. Jefferies, Identiﬁcation and
functional characterization of voltage-dependent calcium channels in T lympho-
cytes, J. Biol. Chem. 278 (2003) 46949–46960.
[27] L. Stokes, J. Gordon, G. Grafton, Non-voltage-gated L-type Ca2+ channels in human
T cells: pharmacology and molecular characterization of the major alpha pore-
forming and auxiliary beta-subunits, J. Biol. Chem. 279 (2004) 19566–19573.
[28] M. Savignac, A. Badou, M. Moreau, M.C. Leclerc, J.C. Guéry, P. Paulet, P. Druet, J.
Ragab-Thomas, L. Pelletier, Protein kinase C-mediated calcium entry dependent
upon dihydropyridine sensitive channels: a T cell receptor-coupled signaling
pathway involved in IL-4 synthesis, FASEB J. 15 (2001) 1577–1579.
[29] M. Savignac, B. Gomes, A. Gallard, S. Narbonnet, M. Moreau, C. Leclerc, P. Paulet,
B. Mariamé, P. Druet, A. Saoudi, G.J. Fournié, J.C. Guéry, L. Pelletier,
Dihydropyridine receptors are selective markers of Th2 cells and can be
targeted to prevent Th2-dependent immunopathological disorders, J. Immunol.
172 (2004) 5206–5212.
[30] T. Yoshimaru, Y. Suzuki, T. Inoue, C. Ra, L-type Ca2+ channels in mast cells:
activation by membrane depolarization and distinct roles in regulating mediator
release from store-operated Ca2 channels, Mol. Immunol. 46 (2009) 1267–1277.
[31] Y. Suzuki, T. Yoshimaru, T. Inoue, C. Ra, Cav1.2 L-type Ca2+ channel protects mast
cells against activation-induced cell death by preventing mitochondrial integrity
disruption, Mol. Immunol. 46 (2009) 2370–2380.
[32] T. Inoue, Y. Suzuki, T. Yoshimaru, C. Ra, Nitric oxide protects mast cells from
activation-induced cell death: the role of the phosphatidylinositol-3 kinase-
Akt-endothelial nitric oxide synthase pathway, J. Leukoc. Biol. 83 (2008)
1218–1229.
[33] Y. Suzuki, T. Yoshimaru, T. Matsui, T. Inoue, O. Niide, S. Nunomura, C. Ra, FcɛRI
signaling of mast cells activates intracellular production of hydrogen peroxide:
role in the regulation of calcium signals, J. Immunol. 171 (2003) 6119–6127.
[34] E.R. Werner, G. Werner-Felmayer, Biopterin analogues: novel nitric oxide
synthase inhibitors with immunosuppressive action, Curr. Drug Metab. 3
(2002) 119–121.
[35] E.R. Werner, A.C. Gorren, R. Heller, G. Werner-Felmayer, B. Mayer, Tetrahydro-
biopterin and nitric oxide: mechanistic and pharmacological aspects, Exp. Biol.
Med. (Maywood) 228 (2003) 1291–1302.
[36] Y. Suzuki, T. Yoshimaru, T. Inoue, S. Nunomura, C. Ra, The high-afﬁnity
immunoglobulin E receptor (FcɛRI) regulates mitochondrial calcium uptake
and a dihydropyridine receptor-mediated calcium inﬂux in mast cells: role of
the FcɛRIβ chain immunoreceptor tyrosine-based activation motif, Biochem.
Pharmacol. 75 (2008) 1492–1503.
[37] B. Gallis, G.L. Corthals, D.R. Goodlett, H. Ueba, F. Kim, S.R. Presnell, D. Figeys, D.G.
Harrison, B.C. Berk, R. Aebersold, M.A. Corson, Identiﬁcation of ﬂow-dependent
endothelial nitric-oxide synthase phosphorylation sites by mass spectrometryand regulation of phosphorylation and nitric oxide production by the
phosphatidylinositol 3-kinase inhibitor LY294002, J. Biol. Chem. 274 (1999)
30101–30108.
[38] T.J. McCabe, D. Fulton, L.J. Roman, W.C. Sessa, Enhanced electron ﬂux and reduced
calmodulin dissociation may explain “calcium-independent” eNOS activation by
phosphorylation, J. Biol. Chem. 275 (2000) 6123–6128.
[39] S. Dimmeler, I. Fleming, B. Fisslthaler, C. Hermann, R. Busse, A.M. Zeiher,
Activation of nitric oxide synthase in endothelial cells by Akt-dependent
phosphorylation, Nature 399 (1999) 601–605.
[40] D. Fulton, J.P. Gratton, T.J. McCabe, J. Fontana, Y. Fujio, K. Walsh, T.F. Franke, A.
Papapetropoulos, W.C. Sessa, Regulation of endothelium-derived nitric oxide
production by the protein kinase Akt, Nature 399 (1999) 597–601.
[41] S. Martin, I. Pombo, P. Poncet, B. David, M. Arock, U. Blank, Immunologic
stimulation of mast cells leads to the reversible exposure of phosphatidylserine in
the absence of apoptosis, Int. Arch. Allergy Immunol. 123 (2001) 249–258.
[42] Y. Suzuki, T. Inoue, T. Yoshimaru, C. Ra, Galectin-3 but not galectin-1 induces mast
cell death by oxidative stress and mitochondrial permeability transition, Biochim.
Biophys. Acta 1783 (2008) 924–934.
[43] N.C. Eastmond, E.M. Banks, J.W. Coleman, Nitric oxide inhibits IgE-mediated
degranulation of mast cells and is the principal intermediate in IFN-γ-induced
suppression of exocytosis, J. Immunol. 159 (1997) 1444–1450.
[44] B.J. Davis, B.F. Flanagan, A.M. Gilﬁllan, D.D. Metcalfe, J.W. Coleman, Nitric oxide
inhibits IgE-dependent cytokine production and Fos and Jun activation in mast
cells, J. Immunol. 173 (2004) 6914–6920.
[45] Y. Sekar, T.C. Moon, S. Muñoz, A.D. Befus, Role of nitric oxide in mast cells:
controversies, current knowledge, and future applications, Immunol. Res. 33
(2005) 223–229.
[46] M. Bidri, S. Ktorza, I. Vouldoukis I, L. Le Goff, P. Debré, J.J. Guillosson, M. Arock,
Nitric oxide pathway is induced by FcɛRI and up-regulated by stem cell factor in
mouse mast cells, Eur. J. Immunol. 27 (1997) 2907–2913.
[47] M. Bidri, F. Féger, S. Varadaradjalou, N. Ben Hamouda, J.J. Guillosson, M. Arock,
Mast cells as a source and target for nitric oxide, Int. Immunopharmacol. 1 (2001)
1543–1558.
[48] M. Gilchrist, M. Savoie, O. Nohara, F.L. Wills, J.L. Wallace, A.D. Befus, AD, Nitric
oxide synthase and nitric oxide production in vivo-derived mast cells, J. Leukoc.
Biol 71 (2002) 618–624.
[49] M. Gilchrist, S.D. McCauley, A.D. Befus, Expression, localization, and regulation of
NOS in human mast cell lines: effects on leukotriene production, Blood 104
(2004) 462–469.
[50] E.J. Swindle, D.D. Metcalfe, J.W. Coleman, Rodent and human mast cells produce
functionally signiﬁcant intracellular reactive oxygen species but not nitric oxide,
J. Biol. Chem. 279 (2004) 48751–48759.
[51] A.M. Martelli, I. Faenza, A.M. Billi, L. Manzoli, C. Evangelisti, F. Falà, L. Cocco,
Intranuclear 3′-phosphoinositide metabolism and Akt signaling: new mechan-
isms for tumorigenesis and protection against apoptosis? Cell. Signal. 18 (2006)
1101–1107.
[52] S. Dimmeler, A.M. Zeiher, Nitric oxide-an endothelial cell survival factor, Cell
Death Differ. 6 (1999) 964–968.
[53] A. Parcellier, L.A. Tintignac, E. Zhuravleva, B.A. Hemmings, PKB and the
mitochondria: AKTing on apoptosis, Cell. Signal. 20 (2007) 21–30.
[54] K. Furuke, P.R. Burd, J.A. Horvath-Arcidiacono, K. Hori, H. Mostowski, E.T. Bloom,
Human NK cells express endothelial nitric oxide synthase, and nitric oxide
protects them from activation-induced cell death by regulating expression of
TNF-α, J. Immunol. 163 (1999) 1473–14780.
